Literature DB >> 17420242

Borrelia burgdorferi binding of host complement regulator factor H is not required for efficient mammalian infection.

Michael E Woodman1, Anne E Cooley, Jennifer C Miller, John J Lazarus, Kathryn Tucker, Tomasz Bykowski, Marina Botto, Jens Hellwage, R Mark Wooten, Brian Stevenson.   

Abstract

The causative agent of Lyme disease, Borrelia burgdorferi, is naturally resistant to its host's alternative pathway of complement-mediated killing. Several different borrelial outer surface proteins have been identified as being able to bind host factor H, a regulator of the alternative pathway, leading to a hypothesis that such binding is important for borrelial resistance to complement. To test this hypothesis, the development of B. burgdorferi infection was compared between factor H-deficient and wild-type mice. Factor B- and C3-deficient mice were also studied to determine the relative roles of the alternative and classical/lectin pathways in B. burgdorferi survival during mammalian infection. While it was predicted that B. burgdorferi should be impaired in its ability to infect factor H-deficient animals, quantitative analyses of bacterial loads indicated that those mice were infected at levels similar to those of wild-type and factor B- and C3-deficient mice. Ticks fed on infected factor H-deficient or wild-type mice all acquired similar numbers of bacteria. Indirect immunofluorescence analysis of B. burgdorferi acquired by feeding ticks from the blood of infected mice indicated that none of the bacteria had detectable levels of factor H on their outer surfaces, even though such bacteria express high levels of surface proteins capable of binding factor H. These findings demonstrate that the acquisition of host factor H is not essential for mammalian infection by B. burgdorferi and indicate that additional mechanisms are employed by the Lyme disease spirochete to evade complement-mediated killing.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17420242      PMCID: PMC1932899          DOI: 10.1128/IAI.01923-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  89 in total

Review 1.  Complement escape of human pathogenic bacteria by acquisition of complement regulators.

Authors:  Peter Kraiczy; Reinhard Würzner
Journal:  Mol Immunol       Date:  2006-01       Impact factor: 4.407

2.  Dual role of interleukin-10 in murine Lyme disease: regulation of arthritis severity and host defense.

Authors:  J P Brown; J F Zachary; C Teuscher; J J Weis; R M Wooten
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

3.  The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi.

Authors:  J Hellwage; T Meri; T Heikkilä; A Alitalo; J Panelius; P Lahdenne; I J Seppälä; S Meri
Journal:  J Biol Chem       Date:  2000-12-11       Impact factor: 5.157

4.  In vivo binding of complement regulator factor H by Streptococcus pneumoniae.

Authors:  Lisa R Quin; Stephanie Carmicle; Sandhya Dave; Michael K Pangburn; Jason P Evenhuis; Larry S McDaniel
Journal:  J Infect Dis       Date:  2005-10-26       Impact factor: 5.226

5.  Lyme borreliosis in selected strains and ages of laboratory mice.

Authors:  S W Barthold; D S Beck; G M Hansen; G A Terwilliger; K D Moody
Journal:  J Infect Dis       Date:  1990-07       Impact factor: 5.226

6.  Temporal analysis of Borrelia burgdorferi Erp protein expression throughout the mammal-tick infectious cycle.

Authors:  Jennifer C Miller; Kate von Lackum; Kelly Babb; Jason D McAlister; Brian Stevenson
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

7.  Distinct patterns of protective antibodies are generated against Borrelia burgdorferi in mice experimentally inoculated with high and low doses of antigen.

Authors:  U E Schaible; L Gern; R Wallich; M D Kramer; M Prester; M M Simon
Journal:  Immunol Lett       Date:  1993-05       Impact factor: 3.685

8.  Differences of two Borrelia burgdorferi strains in complement activation and serum resistance.

Authors:  V Brade; I Kleber; G Acker
Journal:  Immunobiology       Date:  1992-09       Impact factor: 3.144

9.  Complement resistance of Borrelia burgdorferi correlates with the expression of BbCRASP-1, a novel linear plasmid-encoded surface protein that interacts with human factor H and FHL-1 and is unrelated to Erp proteins.

Authors:  Peter Kraiczy; Jens Hellwage; Christine Skerka; Heiko Becker; Michael Kirschfink; Markus M Simon; Volker Brade; Peter F Zipfel; Reinhard Wallich
Journal:  J Biol Chem       Date:  2003-11-07       Impact factor: 5.157

10.  Protective immune responses against West Nile virus are primed by distinct complement activation pathways.

Authors:  Erin Mehlhop; Michael S Diamond
Journal:  J Exp Med       Date:  2006-05-01       Impact factor: 14.307

View more
  23 in total

Review 1.  Complement evasion by human pathogens.

Authors:  John D Lambris; Daniel Ricklin; Brian V Geisbrecht
Journal:  Nat Rev Microbiol       Date:  2008-02       Impact factor: 60.633

2.  Blood treatment of Lyme borreliae demonstrates the mechanism of CspZ-mediated complement evasion to promote systemic infection in vertebrate hosts.

Authors:  Ashley L Marcinkiewicz; Alan P Dupuis; Maxime Zamba-Campero; Nancy Nowak; Peter Kraiczy; Sanjay Ram; Laura D Kramer; Yi-Pin Lin
Journal:  Cell Microbiol       Date:  2019-01-07       Impact factor: 3.715

Review 3.  Complement Evasion by Lyme Disease Spirochetes.

Authors:  Jon T Skare; Brandon L Garcia
Journal:  Trends Microbiol       Date:  2020-05-29       Impact factor: 17.079

4.  Fitness variation of Borrelia burgdorferi sensu stricto strains in mice.

Authors:  Klára Hanincová; Nicholas H Ogden; Maria Diuk-Wasser; Christopher J Pappas; Radha Iyer; Durland Fish; Ira Schwartz; Klaus Kurtenbach
Journal:  Appl Environ Microbiol       Date:  2007-11-02       Impact factor: 4.792

Review 5.  Biology of infection with Borrelia burgdorferi.

Authors:  Kit Tilly; Patricia A Rosa; Philip E Stewart
Journal:  Infect Dis Clin North Am       Date:  2008-06       Impact factor: 5.982

6.  Essential protective role attributed to the surface lipoproteins of Borrelia burgdorferi against innate defences.

Authors:  Qilong Xu; Kristy McShan; Fang Ting Liang
Journal:  Mol Microbiol       Date:  2008-04-28       Impact factor: 3.501

7.  Borrelia burgdorferi complement regulator-acquiring surface protein 2 (CspZ) as a serological marker of human Lyme disease.

Authors:  Peter Kraiczy; Annekatrin Seling; Catherine A Brissette; Evelyn Rossmann; Klaus-Peter Hunfeld; Tomasz Bykowski; Logan H Burns; Matthew J Troese; Anne E Cooley; Jennifer C Miller; Volker Brade; Reinhard Wallich; Sherwood Casjens; Brian Stevenson
Journal:  Clin Vaccine Immunol       Date:  2007-12-26

Review 8.  Borrelia burgdorferi complement regulator-acquiring surface proteins (BbCRASPs): Expression patterns during the mammal-tick infection cycle.

Authors:  Tomasz Bykowski; Michael E Woodman; Anne E Cooley; Catherine A Brissette; Reinhard Wallich; Volker Brade; Peter Kraiczy; Brian Stevenson
Journal:  Int J Med Microbiol       Date:  2007-12-31       Impact factor: 3.473

9.  CspA-mediated binding of human factor H inhibits complement deposition and confers serum resistance in Borrelia burgdorferi.

Authors:  Melisha R Kenedy; Santosh R Vuppala; Corinna Siegel; Peter Kraiczy; Darrin R Akins
Journal:  Infect Immun       Date:  2009-05-18       Impact factor: 3.441

10.  Coordinated expression of Borrelia burgdorferi complement regulator-acquiring surface proteins during the Lyme disease spirochete's mammal-tick infection cycle.

Authors:  Tomasz Bykowski; Michael E Woodman; Anne E Cooley; Catherine A Brissette; Volker Brade; Reinhard Wallich; Peter Kraiczy; Brian Stevenson
Journal:  Infect Immun       Date:  2007-06-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.